Travere Therapeutics (TVTX) Tax Rate (2014 - 2026)
Travere Therapeutics' (TVTX) quarterly Tax Rate came in at 0.33% in Q1 2026, up 42.0% YoY from 0.23% in Q1 2025, and up 107.47% on a QoQ basis from 4.37% in Q4 2025.
Travere Therapeutics (TVTX) Tax Rate (2014 - 2026) Analysis & Trends
Travere Therapeutics (TVTX) has 13 years of Tax Rate data on file, last reported at 0.33% in Q1 2026.
- Quarterly Tax Rate rose 42.0% year-over-year to 0.33% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.85% (down 186.0% YoY) and the FY2025 annual result came in at 2.01%, down 197.0% from the prior year.
- Tax Rate rose to 0.33% in Q1 2026, from 4.37% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 0.33% in Q1 2026 to a low of 4.37% in Q4 2025.
- A 5-year average of 0.29% and a median of 0.07% in 2022 frame the typical range for Tax Rate.
- Annual changes were most pronounced in 2022 — Tax Rate surged 52 bps — and 2025, when it tumbled 449 bps.
- Tracing TVTX's Tax Rate over 5 years: stood at 0.07% in 2022, then slipped by 4 bps to 0.08% in 2023, then soared by 255 bps to 0.12% in 2024, then sank by 3764 bps to 4.37% in 2025, then surged by 107 bps to 0.33% in 2026.
- The last three Tax Rate figures came in at 0.33% (Q1 2026), 4.37% (Q4 2025), and 0.03% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.91% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 24.15% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -9.47% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 7.49% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.71% |
| 10 | Travere Therapeutics | 5.85 Bn | 5.85 Bn | 162.52 Mn | 0.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.58% |
| Jun 30, 2026 | 0.58% |
| Jun 30, 2026 | 0.58% |
| Mar 31, 2026 | 0.33% |
| Mar 31, 2026 | 0.33% |
| Mar 31, 2026 | 0.33% |
| Dec 31, 2025 | -4.37% |
| Dec 31, 2025 | -4.37% |
| Dec 31, 2025 | -4.37% |
| Sep 30, 2025 | 0.03% |
| Sep 30, 2025 | 0.03% |
| Sep 30, 2025 | 0.03% |
| Jun 30, 2025 | -0.16% |
| Jun 30, 2025 | -0.16% |
| Jun 30, 2025 | -0.16% |
| Mar 31, 2025 | -0.09% |
| Mar 31, 2025 | -0.09% |
| Mar 31, 2025 | -0.09% |
| Dec 31, 2024 | 0.12% |
| Dec 31, 2024 | 0.12% |